Related Experiment Video
Updated: Jul 16, 2026
08:03
Cervical Lymph Duct-Cannulated Rat Model for Assessing Lymphatic Transport from the Head and Brain
Published on: March 10, 2026
Diagnostic Considerations for Neurolymphomatosis: A Natural History Analysis
Francesca Rothell1, Mary Ann Nguyen2, Elizabeth Xu3
1Division of Hematology/Oncology, Brown University Health Cancer Institute, Rhode Island Hospital, The Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
Cancers
|July 15, 2026
Summary
Histological confirmation via biopsy improves outcomes for neurolymphomatosis (NL) patients. Combining biopsy with PET, MRI, and EMG-NCS shows a positive trend for diagnosis and patient survival.
Area of Science:
- Neurology
- Oncology
- Diagnostic Imaging
Background:
- Neurolymphomatosis (NL) is a rare, challenging manifestation of non-Hodgkin's lymphoma impacting the peripheral nervous system.
- Optimal diagnostic strategies for NL are crucial for timely intervention and improved patient outcomes.
Purpose of the Study:
- To define an optimal diagnostic approach for neurolymphomatosis.
- To correlate patient outcomes with various diagnostic modalities.
Main Methods:
- Systematic review and analysis of 559 neurolymphomatosis cases from 231 articles (1951-2022).
- Evaluation of diagnostic modalities: MRI, CT, FDG-PET, EMG-NCS, ultrasound, and tissue biopsy.
- Analysis of outcomes based on the use of individual or combined diagnostic methods.
Main Results:
- Patients with biopsy confirmation showed significantly longer survival intervals (from diagnosis and symptom onset) and time to progression.
- A combination of biopsy, PET, MRI, and EMG-NCS demonstrated a positive trend for improved diagnostic yield.
- No significant correlation between diagnostic modalities and outcomes was observed in the non-biopsied population, where secondary NL was more prevalent.
Conclusions:
- Histological confirmation via biopsy is strongly associated with better patient outcomes in neurolymphomatosis.
- Timely diagnosis using a combination of PET, MRI, and EMG-NCS is recommended to guide nerve biopsy.
- Early and accurate diagnosis is critical for effective management of neurolymphomatosis.
